User:Jacob Holt/Sandbox 1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 50: Line 50:
''Step 4'': Another electron/proton pair is brought in to create three H2O molecules and to take the Fe ions back down to their original oxidation state of +2 (Figure 4)<ref name="Yu" />.
''Step 4'': Another electron/proton pair is brought in to create three H2O molecules and to take the Fe ions back down to their original oxidation state of +2 (Figure 4)<ref name="Yu" />.
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
== Regulation of Enzyme ==
== Regulation of Enzyme ==
Line 82: Line 57:
== Biological Relevance ==
== Biological Relevance ==
[[Image:scd_in_membrane.jpeg|500 px|thumb|Figure 5. Position of SCD within the biological membrane. It is part of an electron transport chain involving cytochrome b5 reductase and cytochrome b5 to allow for the activation of the catalytic molecule coordinated by the two ions in the center of SCD]]Absence or a deficit of SCD1 in the body is associated with obesity and insulin resistant which is a main cause of Type II diabetes [https://en.wikipedia.org/wiki/Type_2_diabetes type 2 diabetes]<ref name="Shen" />. Cancer sites in the body tend to show a much higher expression rate of SCD1<ref name="Shen" />. Focusing on SCD1 as a drug target could lead to advancements in treatment of obesity, diabetes, and other metabolic diseases<ref name="Bai" />. The ligand structure was determined by using Zn2+ metal ions and product structure was determined using Fe2+ ions<ref name="Shen" />.
[[Image:scd_in_membrane.jpeg|500 px|thumb|Figure 5. Position of SCD within the biological membrane. It is part of an electron transport chain involving cytochrome b5 reductase and cytochrome b5 to allow for the activation of the catalytic molecule coordinated by the two ions in the center of SCD]]Absence or a deficit of SCD1 in the body is associated with obesity and insulin resistant which is a main cause of Type II diabetes [https://en.wikipedia.org/wiki/Type_2_diabetes type 2 diabetes]<ref name="Shen" />. Cancer sites in the body tend to show a much higher expression rate of SCD1<ref name="Shen" />. Focusing on SCD1 as a drug target could lead to advancements in treatment of obesity, diabetes, and other metabolic diseases<ref name="Bai" />. The ligand structure was determined by using Zn2+ metal ions and product structure was determined using Fe2+ ions<ref name="Shen" />.
 +
 +
== References ==
== References ==

Revision as of 13:38, 25 April 2021

Desaturation of Fatty Acids using Stearoyl-CoA Desaturase-1 Enzyme

SCD1 Protein 4ymk

Drag the structure with the mouse to rotate



Student Contributions

Carson Maris, Jess Kersey, Jacob Holt

Proteopedia Page Contributors and Editors (what is this?)

Jacob Holt

Personal tools